Clinical Trial: Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fed Conditions

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07698288) titled 'Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fed Conditions' on July 07.

Brief Summary: Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x4, replicated, two treatments, four periods, two sequences controlled clinical study

Study Start Date: Feb. 12

Study Type: INTERVENTIONAL

Condition: Bioequivalence

Intervention: DRUG: Tamsulosin 0.4 mg ER tablet

TEST

DRUG: Tamsulosin 0.4 mg ER tablet

REFERENCE

Recruitment Status: COMPLETED

Sponsor: ADIUM

Published by HT Digital Content Services with permission from Health Dail...